Protein Expression Systems Market
- 2026 年市場規模
- USD 2.9 Bn
- 2033 年預估規模
- USD 6.0 Bn
- 年複合成長率 CAGR
- 11%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Protein Expression Systems Market, By Expression System (Mammalian Expression Systems, Insect Expression Systems, Bacterial Expression Systems, Plant Expression Systems, Yeast Expression Systems, and Cell Free Expression Systems), By Product Type (Competent Cells, Instruments, Reagents, and Others), By Application (Protein Therapeutics, and Research Studies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
報告摘要
Protein expression is an integral tool in biological research and it is gaining significant traction as a pharmaceutical production mechanism for biological therapeutics. The biotechnology industry uses both cell types prokaryotic (bacteria) and eukaryotic (animal, fungi, and plant) to synthesize recombinant proteins. The choice of the host cell depends on the protein expressed. The demand for recombinant proteins has increased as more applications in several fields are commercially available. Recombinant proteins have been utilized as tools for cellular and molecular biology.
Market Dynamics
The demand for protein therapeutics has increased considerably, owing to increase in prevalence of chronic diseases and development of plasma-derived therapies. In recent years, proteins expression systems have gained significant traction for therapeutic applications and the number of proteins launched or approved into clinical trials has continually increased. According to the National Center for Biotechnology Information (NCBI) data of 2017, the U.S. Food and Drug Administration (FDA) approved more than 140 recombinant therapeutic proteins for human use and several hundred are currently in development.
However, high cost associated with therapeutic proteins and stringent government regulations towards approval of protein therapies are expected to hinder market growth. For instance, in India, a vial of Avastin (Bevacizumab mostly produced by the mammalian cell expression system), a monoclonal antibody, cost between USD 372.65 to USD 402.46. Moreover, immunogenicity is also a major concern for all recombinant drugs, as all biotechnologically produced therapeutics may exhibit some form of immunogenicity.
Key features of the study
• This report provides in-depth analysis of the protein expression systems market, market size (USD Bn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2026 – 2033, considering 2025, as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
• It profiles key players in the global protein expression systems market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
• Key players covered as a part of this study include Agilent Technologies, Inc., Becton, Dickinson & Company, Lonza Group Ltd., GenScript Biotech Corporation, Bio-Rad Laboratories, Inc., Merck KGaA, QIAGEN N.V., Thermo Fisher Scientific Inc., Takara Bio Inc., Synthetic Genomics Inc., Lucigen Corporation, Promega Corporation, ARTES Biotechnology GmbH, ProteoGenix, Addgene Inc., Geneva Biotech, Profacgen, and Peak Proteins Ltd.
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
• The global protein expression systems market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for protein expression systems market, research and consulting firms, new entrants, and financial analysts
Market Segmentation
• By Expression System Insights (Revenue, USD Bn, 2021 - 2033)
o Mammalian Expression Systems
o Insect Expression Systems
o Bacterial Expression Systems
o Plant Expression Systems
o Yeast Expression Systems
o Cell Free Expression Systems
• By Product Type Insights (Revenue, USD Bn, 2021 - 2033)
o Competent Cells
o Instruments
o Reagents
o Others
• By Application Insights (Revenue, USD Bn, 2021 - 2033)
o Protein Therapeutics
o Research Studies
• By Region Insights (Revenue, USD Bn, 2021 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players
o Agilent Technologies, Inc.
o Becton, Dickinson & Company
o Lonza Group Ltd.
o GenScript Biotech Corporation
o Bio-Rad Laboratories, Inc.
o Merck KGaA
o QIAGEN N.V.
o Thermo Fisher Scientific Inc.
o Takara Bio Inc.
o Synthetic Genomics Inc.
o Lucigen Corporation
o Promega Corporation
o ARTES Biotechnology GmbH
o ProteoGenix
o Addgene Inc.
o Geneva Biotech
o Profacgen
o Peak Proteins Ltd.
目錄 Table of Contents
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Expression System
Market Snippet, By Product Type
Market Snippet, By Application
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Market Trends
o Key Developments
o Technological Advancements
o Regulatory Landscape
o New Product Launches/Approvals
o Research and Development Activities
o PEST Analysis
4. Global Protein Expression Systems Market, By Expression System, 2021 – 2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Mammalian Expression Systems
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
o Insect Expression Systems
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
o Bacterial Expression Systems
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
o Plant Expression Systems
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
o Yeast Expression Systems
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
o Cell Free Expression Systems
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
5. Global Protein Expression Systems Market, By Product Type, 2021 – 2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Competent Cells
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
o Instruments
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
o Reagents
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
6. Global Protein Expression Systems Market, By Application, 2021 – 2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Protein Therapeutics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
o Research Studies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
7. Global Protein Expression Systems Market, By Region, 2021 – 2033, (USD Bn)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, By Region, 2022 – 2033
Regional Trends
o North America
Market Size and Forecast, By Expression System, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Product Type, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Application, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Country, 2021 – 2033, (USD Bn)
o U.S.
o Canada
o Europe
Market Size and Forecast, By Expression System, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Product Type, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Application, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Country, 2021 – 2033, (USD Bn)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Market Size and Forecast, By Expression System, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Product Type, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Application, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Country, 2021 – 2033, (USD Bn)
o China
o Japan
o India
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Latin America
Market Size and Forecast, By Expression System, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Product Type, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Application, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Country, 2021 – 2033, (USD Bn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Africa
Market Size and Forecast, By Expression System, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Product Type, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Application, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Country, 2021 – 2033, (USD Bn)
o North Africa
o Central Africa
o South Africa
o Middle East
Market Size and Forecast, By Expression System, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Product Type, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Application, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Country, 2021 – 2033, (USD Bn)
o GCC Countries
o Israel
o Rest of Middle East
8. Competitive Landscape
o Heat Map Analysis
o Company Profiles
Agilent Technologies, Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Becton, Dickinson & Company
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Lonza Group Ltd.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
GenScript Biotech Corporation
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Bio-Rad Laboratories, Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Merck KGaA
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
QIAGEN N.V.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Thermo Fisher Scientific Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Takara Bio Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Synthetic Genomics Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Lucigen Corporation
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Promega Corporation
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
ARTES Biotechnology GmbH
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
ProteoGenix
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Addgene Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Geneva Biotech
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Profacgen
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Peak Proteins Ltd.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
9. Section
o References
o Research Methodology
o About Us and Sales Contact
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們